Royalty Pharma plc (RPRX) Operating income 2018–2025
Royalty Pharma plc (RPRX) annual operating income history from SEC filings — each fiscal year as reported.
$1.6BFY2025 · since FY2018: $1.4B → $1.6B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.6B | +20.7% |
| FY2024 | $1.3B | -13.4% |
| FY2023 | $1.5B | +385.9% |
| FY2022 | $307.1M | -78.5% |
| FY2021 | $1.4B | -10.3% |
| FY2020 | $1.6B | -39.2% |
| FY2019 | $2.6B | +92.3% |
| FY2018 | $1.4B | — |
Source: SEC XBRL filings · For reference only · Not investment advice